Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Public ClinicalTrials.gov record NCT00044759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multi-Center, Comparative Study of the Efficacy and Safety of Piperacillin/Tazobactam to Cefepime for the Empiric Treatment of Neutropenic Fever in Patients With a Hematologic Malignancy or Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the safety and efficacy of piperacillin/tazobactam (4 g/500 mg) administered intravenously every 6 hours to cefepime (2 g) administered intravenously every 8 hours for the empiric treatment of neutropenic fever in patients with a hematologic malignancy or lymphoma.
Study identification
- NCT ID
- NCT00044759
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Jan 2003 (Actual)
- Last update posted
- Oct 10, 2007
Ends 2003
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Los Angeles | California | 90089 | — |
| Not listed | Denver | Colorado | 80205 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | North Miami | Florida | 33169 | — |
| Not listed | Ocala | Florida | 34474 | — |
| Not listed | St. Petersburg | Florida | 33705 | — |
| Not listed | Thomasville | Georgia | 31792 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Camden | New Jersey | 08103 | — |
| Not listed | Hackensack | New Jersey | 7601 | — |
| Not listed | Buffalo | New York | 14263 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | Rochester | New York | 14621 | — |
| Not listed | Rochester | New York | 14642-8668 | — |
| Not listed | The Bronx | New York | 10466 | — |
| Not listed | Valhalla | New York | 10595 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Sayre | Pennsylvania | 18840 | — |
| Not listed | Upland | Pennsylvania | 19013 | — |
| Not listed | West Reading | Pennsylvania | 19611 | — |
| Not listed | Providence | Rhode Island | 02908 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Morgantown | West Virginia | 26506-9162 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00044759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2007 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00044759 live on ClinicalTrials.gov.